PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Posts navigation

1 2 … 12 Next
UK life sciences get £650 million growth package

UK life sciences get £650 million growth package

Chancellor Jeremy Hunt has announced a comprehensive ‘Life Sci for Growth’ package of support for the UK life sciences sector, designed to grow the economy through improving regulation around clinical trials, manufacturing, skills and infrastructure.

5 Jun 2023
Read More
Award for PharmaMedic’s Managing Director

Award for PharmaMedic’s Managing Director

We are excited to report that PharmaMedic's Managing Director, Dr Malcolm Barratt-Johnson has received a Global Fellow in Medicines Development (GFMD) award from the respected GMDP Academy.

1 Jun 2023
Read More
EMA annual report reviews actions in 2022

EMA annual report reviews actions in 2022

The European Medicines Agency (EMA) has published its annual report for 2022, highlighting its challenges and successes in a year that saw it face ongoing and new public health emergencies.

24 May 2023
Read More
Developments in UK mental health treatments

Developments in UK mental health treatments

With Mental Health Awareness Week 2023 having taken place from 15-21 May and focusing on anxiety, what advances have there been in this field to support those with mental health conditions? We examine the status of mental health therapy demand in the UK and whether the provision of digitally enabled treatments could be one way to help ease waiting times.

23 May 2023
Read More
US FDA issues draft guidance on decentralised clinical trials

US FDA issues draft guidance on decentralised clinical trials

Decentralised clinical trials (DCTs) are being used increasingly in the pharma industry for clinical research and the US Food and Drug Administration (FDA) has published draft guidance for those carrying out trials at non-traditional investigation sites.

18 May 2023
Read More
New Integrated Pathology Unit to speed cancer diagnosis

New Integrated Pathology Unit to speed cancer diagnosis

Cancer diagnosis and treatment are set to be accelerated with the opening of England’s first Integrated Pathology Unit (IPU). The new facility will apply pioneering digital imaging and artificial intelligence to pathology, assisting clinical trial research programmes focused on developing tests for cancer.

17 May 2023
Read More
Will ABPI’s ambitious VPAG plans succeed VPAS?

Will ABPI’s ambitious VPAG plans succeed VPAS?

Discussions are beginning on the next iteration of the UK’s voluntary scheme for branded medicines, pricing and access (VPAS) and the Association of the British Pharmaceutical Industry (ABPI) has set out its stall to government. It has published a four-point proposal for a Voluntary Scheme for Pricing, Access and Growth (VPAG), designed to reignite competitiveness and boost innovation in the life sciences sector, thereby improving health outcomes and the wider economy.

15 May 2023
Read More
EC’s plans for updating pharma legislation unveiled

EC’s plans for updating pharma legislation unveiled

The European Commission’s (EC) long-awaited proposals for reforming pharma legislation have been published. The main thrust of the proposals is to create a single EU market for medicines to replace existing fragmentation and improve access for EU citizens.

11 May 2023
Read More
The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 annual conference of the UK’s Association of the British Pharmaceutical Industry (ABPI) at the end of April had a theme of Growing the UK as a Global Hub for Life Sciences.

9 May 2023
Read More
NICE extends international collaboration to streamline processes

NICE extends international collaboration to streamline processes

The UK’s National Institute for health and Care Excellence (NICE) has announced that it will be working closely with the Canadian Agency for Drugs and Technologies in Health (CADTH) and the US Institute for Clinical and Economic Review (ICER) to find common ground and smooth processes around the handling of confidential information about health technologies.

4 May 2023
Read More

Posts navigation

1 2 … 12 Next

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HTA #innovation #lifesciences #marketaccess #MDR #medicaldevice #medicaldeviceregulation #medicinesaccess #mentalhealth #mhra #NHS #NICE #pharmaregulation #pre-eclampsia #R&D #rarediseaseresearch #rarediseases #regulation #regulatory #research #UKgovernment #ukregulation #VPAS AI Biotech COVID-19 Healthcare IR35 Medical Affairs medicaldevices Pharma UKmedicines
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital